Introduction MicroRNAs (miRNAs) are small non-coding RNA that plays a vital role in cancer
progression. Neo-adjuvant chemotherapy (NAC) has become the standard of care for locally …

Aim: To identify the association of serum miRNAs with neoadjuvant polychemotherapy
response in patients with breast cancer of luminal A and B subtypes. Materials and Methods …

Background Chemotherapy is an important component in the treatment paradigm for breast
cancers. However, the resistance of cancer cells to chemotherapeutic agents frequently …

Purpose miRNAs have been linked to chemosensitivity of breast cancer cells in vitro. In
patients, however, there is no clinically validated method for predicting chemotherapy …

Neoadjuvant chemotherapy (NACT) is used in locally advanced breast cancer to reduce
tumour burden prior to surgical resection. However, only a subset of NACT treated patients …

The predictive value of serum miRNAs (ser-miRNA) for the response to neoadjuvant
chemotherapy (NCT) and the prognosis of breast cancer patients were investigated in the …

Breast cancer (BC) is a leading cause of cancer-related deaths among women worldwide.
Neoadjuvant therapy (NAT) is increasingly being used to reduce tumor burden prior to …

Circulating microRNAs (miRNAs) have been extensively studied in cancer as biomarkers
but little is known regarding the influence of anti‐cancer drugs on their expression levels. In …

Purpose Accumulating evidence has shown that microRNAs (miRNAs) are promising
biomarkers of neoadjuvant chemotherapy (NAC) response in breast cancer (BC). However …

Background Circulating micro RNA s (mi RNA s) have been indicated as predictive
biomarkers in breast cancer. We aimed to explore the association of plasma mi RNA …